Previous Danish general population studies (<10% had diabetes) have shown that elevated YKL-40 is associated with an increased risk of developing gastrointestinal cancers and possibly lung cancer, but not with breast or prostate cancers [2, 12, 13]. This evidence concerns the gene CHI3L1 and prostate carcinoma.